FIGURE 7.
Effect of donor-derived AD- and BM-MSCs and their EVs treatments on infiltrating immune cell in kidney graft. (A) T cells, CD3+. (B) Thelpers + Treg cells, CD3+CD4+. (C) Tcytotoxic cells, CD3+CD8+. (D), NK cells, CD3–CD314+CD161+. (E) B cells, CD3–CD161–B220+. ∗Significantly different when compared to F-L + Ø group (*P < 0.05; **P < 0.01).